These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7804511

  • 1. Urapidil in hypercholesterolemic hypertensive patients.
    Ferrara LA, Leonetti G, Fogari R, Mazzola C, Mancini M, Zanchetti A.
    Blood Press Suppl; 1994; 4():39-44. PubMed ID: 7804511
    [Abstract] [Full Text] [Related]

  • 2. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The effect of urapidil on blood pressure, renal hemodynamics, lipid and glucose metabolism].
    Sanjuliani AF, Fagundes VG, Francischetti EA.
    Arq Bras Cardiol; 1995 Jul; 65(1):59-63. PubMed ID: 8546598
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 8. [Antihypertensive effect and tolerance to urapidil. Comparison with nifedipine in a multicenter double-blind study].
    Stumpe KO, Feldhaus P, Haerlin R.
    Fortschr Med; 1989 Jan 15; 107(1):54-7. PubMed ID: 2646188
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of different antihypertensive drugs in the emergency department.
    Hirschl MM, Seidler D, Müllner M, Kürkciyan I, Herkner H, Bur A, Laggner AN.
    J Hum Hypertens; 1996 Sep 15; 10 Suppl 3():S143-6. PubMed ID: 8872847
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
    Rump LC, Baranova E, Okopien B, Weisskopf M, Kandra A, Ferber P.
    Clin Ther; 2008 Oct 15; 30(10):1782-93. PubMed ID: 19014834
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD.
    Clin Ther; 1994 Oct 15; 16(3):490-504. PubMed ID: 7923316
    [Abstract] [Full Text] [Related]

  • 16. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 15; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of urapidil in the management of essential hypertension: a comparison with captopril.
    Rosenthal J, Haerlin R.
    J Hypertens Suppl; 1988 Dec 15; 6(2):S69-71. PubMed ID: 3068344
    [Abstract] [Full Text] [Related]

  • 18. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ, Jaguste V, Nanivadekar AS.
    J Assoc Physicians India; 1998 Dec 15; Suppl 1():41-51. PubMed ID: 11233386
    [Abstract] [Full Text] [Related]

  • 19. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G, Italian Study Group on Nilvadipine in Mild to Moderate Hypertension.
    Curr Med Res Opin; 2005 Jun 15; 21(6):951-8. PubMed ID: 15969895
    [Abstract] [Full Text] [Related]

  • 20. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep 15; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.